Point72 Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,524,485	Closed	-$48.7M	–	1992
2022 Q2	$48.7M	Buy	1,524,485 +604,285	+66%	+$17.7M	0.23%	126
2022 Q1	$31.9M	Buy	920,200 +736,729	+402%	+$22M	0.14%	216
2021 Q4	$5.37M	Sell	183,471 -2,129,129	-92%	-$66M	0.02%	647
2021 Q3	$58.9M	Buy	2,312,600 +251,000	+12%	+$7.38M	0.28%	82
2021 Q2	$72.2M	Buy	2,061,600 +736,118	+56%	+$28.7M	0.36%	64
2021 Q1	$54M	Buy	1,325,482 +1,272,802	+2,416%	+$58.5M	0.28%	95
2020 Q4	$2.28M	Buy	+52,680	New	+$2.6M	0.01%	711
2020 Q3	–	Sell	-214,113	Closed	-$13.6M	–	1182
2020 Q2	$13.5M	Sell	214,113 -73,304	-26%	-$5.03M	0.09%	274
2020 Q1	$14.7M	Sell	287,417 -177,264	-38%	-$11.9M	0.12%	248
2019 Q4	$36.9M	Sell	464,681 -243,127	-34%	-$14.4M	0.21%	153
2019 Q3	$34.3M	Buy	+707,808	New	+$36.9M	0.22%	136
2018 Q3	–	Sell	-435,900	Closed	-$19.7M	–	1345
2018 Q2	$19.7M	Buy	+435,900	New	+$19.8M	0.1%	307
2018 Q1	–	Sell	-226,300	Closed	-$12.6M	–	1232
2017 Q4	$8.9M	Sell	226,300 -1,796,400	-89%	-$67.1M	0.05%	469
2017 Q3	$62.8M	Buy	2,022,700 +1,323,934	+189%	+$37.2M	0.37%	89
2017 Q2	$19.1M	Buy	698,766 +287,666	+70%	+$8.56M	0.13%	259
2017 Q1	$15.1M	Buy	+411,100	New	+$10.4M	0.09%	300
2016 Q2	–	Sell	-112,300	Closed	-$1.78M	–	945
2016 Q1	$1.78M	Buy	+112,300	New	+$2M	0.02%	570